Congratulations to our first three pump priming awardees and their collaborating partners whose projects will start in spring 2018!
Dr Qibo Zhang from the Institute of Infection and Global Health, University of Liverpool will be leading the project “Elucidating the effect of maternal immunisation on the subsequent development of T cell response following pertussis vaccination in infants” that will be implemented together with the two Co-PIs Prof. Elke Leuridan from the Centre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, University of Antwerp, Belgium and Prof. Yong Poovorawan from the Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Thailand.
Simon Gwapa Kimuda from the Department of Immunomodulation and Vaccines, Medical Research Council/UVRI Uganda Research Unit on AIDS, will be using in vitro mycobacterial growth inhibition assays as a tool to assess functional immune responses induced by VPM1002 vaccination in infants.
He will be working with Prof. Alison Elliott, Head of Immunomodulation and Vaccines Programme, Medical Research Council/UVRI Uganda Research Unit on AIDS and Prof. Gerhard Walzl, Head of the Department of Biomedical Sciences, Stellenbosch University, South Africa.
Dr Sudaxshina Murdan from the UCL School of Pharmacy, University College London, will work on oral vaccines which generate immune responses in the vagina and prevent mother-to-baby transmission of infections during birth.
In this project she will be collaborating with Prof Abdul Basit from the UCL School of Pharmacy, University College London and Dr Fatme Mawas from the National Institute for Biological Standards and Control (NIBSC), UK.
All selected projects address key challenges of IMPRINT and include collaborations between HIC and LMIC countries to foster and strengthen our maternal vaccine network. They will be funded with a max of £70,000 per project and for a duration of up to 12 months. Full abstracts and further details will be published here soon.
UK Research and Innovation (UKRI) has published information regarding the impact of the COVID-19 pandemic on UKRI-supported research which includes IMPRINT grants and projects.